Impact of Routine Unilateral Central Neck Dissection on Preablative and Postablative Stimulated Thyroglobulin Levels after Total Thyroidectomy in Papillary Thyroid Carcinoma

作者: Brian Hung-Hin Lang , Kai Pun Wong , Koon Yat Wan , Chung Yau Lo

DOI: 10.1245/S10434-011-1833-X

关键词: Prospective cohort studyMedicineStage (cooking)ThyroglobulinThyroidectomyNeck dissectionLymph nodeHypoparathyroidismCarcinomaSurgery

摘要: Prophylactic central neck dissection (CND) remains controversial in papillary thyroid carcinoma (PTC). Because postsurgical stimulated thyroglobulin (sTg) level is a good surrogate for recurrence, the study aimed to evaluate impact of prophylactic CND on preablative and postablative sTg levels after total thyroidectomy. Of 185 patients retrospectively analyzed, 82 (44.3%) underwent thyroidectomy (CND-positive group) while 103 (55.7%) only (CND-negative group). All had no preoperative or intraoperative evidence lymph node metastases. Clinicopathological characteristics, postoperative outcomes, were compared between two groups. Preablative was taken at time radioiodine ablation, 6 months ablation. A multivariable analysis conducted identify factors athyroglobulinemia (sTg < 0.5 μg/L). Relative CND-negative group, CND-positive group larger tumors (15 mm vs. 10 mm, P < 0.005), more extrathyroidal extension (26.8% 14.6%, P < 0.003), tumor, node, metastasis system stage III disease (32.9% 9.7%, P < 0.001), temporary hypoparathyroidism (18.3% 8.7%, P = 0.017). Fourteen (17.1%) upstaged from stages I/II as result CND. The experienced lower median (<0.5 μg/L 6.7 μg/L, P < 0.001) higher rate (51.2% 22.3%, P = 0.024), but these differences not observed independent factor athyroglobulinemia. Although performing may offer complete initial tumor resection than alone by minimizing any residual microscopic disease, such difference becomes less noticeable

参考文章(27)
Stéphane Bonnet, Dana Hartl, Sophie Leboulleux, Eric Baudin, Jean D. Lumbroso, Abir Al Ghuzlan, Linda Chami, Martin Schlumberger, Jean Paul Travagli, Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment. The Journal of Clinical Endocrinology and Metabolism. ,vol. 94, pp. 1162- 1167 ,(2009) , 10.1210/JC.2008-1931
Robert C. Smallridge, Shon E. Meek, Melissa A. Morgan, Geoffrey S. Gates, Thomas P. Fox, Stefan Grebe, Vahab Fatourechi, Monitoring thyroglobulin in a sensitive immunoassay has comparable sensitivity to recombinant human tsh-stimulated thyroglobulin in follow-up of thyroid cancer patients. The Journal of Clinical Endocrinology and Metabolism. ,vol. 92, pp. 82- 87 ,(2007) , 10.1210/JC.2006-0993
Luca Giovanella, Luca Ceriani, Sergio Suriano, Antonella Ghelfo, Marco Maffioli, Thyroglobulin measurement before rhTSH-aided 131I ablation in detecting metastases from differentiated thyroid carcinoma. Clinical Endocrinology. ,vol. 69, pp. 659- 663 ,(2008) , 10.1111/J.1365-2265.2008.03244.X
Michael A. Rosenbaum, Christopher R. McHenry, Central Neck Dissection for Papillary Thyroid Cancer Archives of Otolaryngology-head & Neck Surgery. ,vol. 135, pp. 1092- 1097 ,(2009) , 10.1001/ARCHOTO.2009.158
Wen T. Shen, Lauren Ogawa, Daniel Ruan, Insoo Suh, Quan-Yang Duh, Orlo H. Clark, Central neck lymph node dissection for papillary thyroid cancer: the reliability of surgeon judgment in predicting which patients will benefit. Surgery. ,vol. 148, pp. 398- 403 ,(2010) , 10.1016/J.SURG.2010.03.021
Brian Hung-Hin Lang, Chung-Yau Lo, Wai-Fan Chan, King-Yin Lam, Koon-Yat Wan, None, Staging Systems for Papillary Thyroid Carcinoma: A Review and Comparison Annals of Surgery. ,vol. 245, pp. 366- 378 ,(2007) , 10.1097/01.SLA.0000250445.92336.2A
Karen A. Heemstra, Ying Y. Liu, Marcel Stokkel, Job Kievit, Eleonora Corssmit, Alberto M. Pereira, Johannes A. Romijn, Johannes W. A. Smit, Serum thyroglobulin concentrations predict disease‐free remission and death in differentiated thyroid carcinoma Clinical Endocrinology. ,vol. 66, pp. 58- 64 ,(2006) , 10.1111/J.1365-2265.2006.02685.X
Tae Yong Kim, Won Bae Kim, Eun Sook Kim, Jin Sook Ryu, Jeong Seok Yeo, Seong Chul Kim, Suck Joon Hong, Young Kee Shong, Serum thyroglobulin levels at the time of 131I remnant ablation just after thyroidectomy are useful for early prediction of clinical recurrence in low-risk patients with differentiated thyroid carcinoma. The Journal of Clinical Endocrinology and Metabolism. ,vol. 90, pp. 1440- 1445 ,(2005) , 10.1210/JC.2004-1771
Richard T. Kloos, Ernest L. Mazzaferri, A Single Recombinant Human Thyrotropin-Stimulated Serum Thyroglobulin Measurement Predicts Differentiated Thyroid Carcinoma Metastases Three to Five Years Later The Journal of Clinical Endocrinology and Metabolism. ,vol. 90, pp. 5047- 5057 ,(2006) , 10.1210/JC.2005-0492